Pressure Biosciences Correlations

PBIODelisted Stock  USD 0.49  0.00  0.00%   
The current 90-days correlation between Pressure Biosciences and ImmuCell is 0.05 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pressure Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pressure Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Pressure Biosciences Correlation With Market

Significant diversification

The correlation between Pressure Biosciences and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pressure Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Pressure Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pressure Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pressure Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pressure Biosciences to buy it.

Moving together with Pressure OTC Stock

  0.69VERO Venus ConceptPairCorr
  0.77DYNT DynatronicsPairCorr
  0.76PHG Koninklijke PhilipsPairCorr
  0.76BBLGW Bone Biologics CorpPairCorr
  0.88SNN Smith Nephew SNATSPairCorr
  0.77STE STERIS plcPairCorr
  0.61HSDT Helius Medical TechnPairCorr
  0.77ZIMV ZimVie IncPairCorr

Moving against Pressure OTC Stock

  0.9NXL Nexalin TechnologyPairCorr
  0.88PEN PenumbraPairCorr
  0.86ELMD ElectromedPairCorr
  0.85ECOR Electrocore LLCPairCorr
  0.74OM Outset MedicalPairCorr
  0.73BSX Boston Scientific CorpPairCorr
  0.72MYO Myomo IncPairCorr
  0.72SYK StrykerPairCorr
  0.58DXCM DexCom IncPairCorr
  0.51ABT Abbott Laboratories Fiscal Year End 22nd of January 2025 PairCorr
  0.48WOK WORK Medical TechnologyPairCorr
  0.42FNA Paragon 28PairCorr
  0.4BIO Bio Rad LaboratoriesPairCorr
  0.37BVS BioventusPairCorr
  0.87GMED Globus MedicalPairCorr
  0.86MASI MasimoPairCorr
  0.85LUCD Lucid DiagnosticsPairCorr
  0.75GKOS Glaukos CorpPairCorr
  0.75IART Integra LifeSciencesPairCorr
  0.74IRMD IradimedPairCorr
  0.72INMD InModePairCorr
  0.71ITGR Integer Holdings CorpPairCorr
  0.65IRTC iRhythm TechnologiesPairCorr
  0.5ICCM Icecure MedicalPairCorr
  0.44ICAD icad incPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SNWVPDEX
PUREICCC
PARDICCC
PARDPDEX
PARDSNWV
PUREPARD
  
High negative correlations   
SNWVICCC
PUREPDEX
PURESNWV
PDEXICCC
PUREPARD
PARDSNWV

Risk-Adjusted Indicators

There is a big difference between Pressure OTC Stock performing well and Pressure Biosciences OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pressure Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Pressure Biosciences Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pressure Biosciences otc stock to make a market-neutral strategy. Peer analysis of Pressure Biosciences could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Pressure Biosciences?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.